🟢 Veradermics is trading 4% up in pre-market amid broader risk-on trading; catalyst unconfirmed

Veradermics is trading at $120.36, up +4.01%, as higher U.S. futures provide a modest broader risk-on backdrop.

• The Nasdaq Composite is up 0.51%; the specific catalyst remains unconfirmed, and low-liquidity pre-market trading may also contribute.
• No fresh company-specific announcement, earnings release, regulatory decision, or analyst action was identified for September 25, 2026.
• The latest investor-relations update concerns September conference appearances.